Levy Richard S Insider Trading Activity
Levy Richard S has been net-selling over the last 12 months with 0 purchases and 25 sales across 1 company.
MDGL is the most-traded position with 25 trades. The largest single transaction was a sale of MDGL for $775K on May 22, 2026.
Performance Scorecard
Forward stock performance after each transaction by Levy Richard S. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.0% | 24% | 25 |
| 90 days | — | +7.9% | 100% | 14 |
| 120 days | — | +14.8% | 100% | 14 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersMDGL · MADRIGAL PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Levy Richard S bought and sold MDGL.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 22, 2026 | MDGL | Sell | 40 | $506.68 | $20K | −0.1% | Director | |
May 22, 2026 | MDGL | Sell | 320 | $508.24 | $163K | −1.2% | Director | |
May 22, 2026 | MDGL | Sell | 151 | $510.36 | $77K | −0.6% | Director | |
May 22, 2026 | MDGL | Sell | 610 | $511.40 | $312K | −2.2% | Director | |
May 22, 2026 | MDGL | Sell | 439 | $512.50 | $225K | −1.7% | Director | |
May 22, 2026 | MDGL | Sell | 343 | $514.67 | $177K | −1.3% | Director | |
May 22, 2026 | MDGL | Sell | 657 | $515.92 | $339K | −2.6% | Director | |
May 22, 2026 | MDGL | Sell | 723 | $516.87 | $374K | −2.9% | Director | |
May 22, 2026 | MDGL | Sell | 1,497 | $517.59 | $775K | −6.1% | Director | |
May 22, 2026 | MDGL | Sell | 782 | $518.76 | $406K | −3.4% | Director | |
May 22, 2026 | MDGL | Sell | 80 | $519.98 | $42K | −0.4% | Director | |
Nov 13, 2025 | MDGL | Sell | 146 | $514.67 | $75K | −0.5% | Director | |
Nov 13, 2025 | MDGL | Sell | 919 | $515.64 | $474K | −3.1% | Director | |
Nov 13, 2025 | MDGL | Sell | 645 | $517.51 | $334K | −2.3% | Director | |
Nov 13, 2025 | MDGL | Sell | 835 | $518.53 | $433K | −3.0% | Director | |
Nov 13, 2025 | MDGL | Sell | 1,355 | $519.67 | $704K | −5.0% | Director | |
Nov 13, 2025 | MDGL | Sell | 308 | $520.68 | $160K | −1.2% | Director | |
Nov 13, 2025 | MDGL | Sell | 1,094 | $521.79 | $571K | −4.3% | Director | |
Nov 13, 2025 | MDGL | Sell | 1,434 | $522.70 | $750K | −5.9% | Director | |
Nov 13, 2025 | MDGL | Sell | 811 | $523.66 | $425K | −3.5% | Director | |
Nov 13, 2025 | MDGL | Sell | 153 | $524.49 | $80K | −0.7% | Director | |
Nov 13, 2025 | MDGL | Sell | 120 | $526.68 | $63K | −0.5% | Director | |
Nov 13, 2025 | MDGL | Sell | 200 | $527.85 | $106K | −0.9% | Director | |
Nov 13, 2025 | MDGL | Sell | 440 | $528.60 | $233K | −2.0% | Director | |
Nov 13, 2025 | MDGL | Sell | 40 | $530.21 | $21K | −0.2% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 25 | $7.3M |
Other insiders at MADRIGAL PHARMACEUTICALS, INC.
8 other tracked filers at MDGL.